Polypeptides having lysophospholipase activity and nucleic acids encoding same
CA 2848113 A1 · Owner: Novozymes, Inc. · Inventors: Klotz, Alan; Tsutsumi, Noriko; Rey, Michael W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to isolated polypeptides having lysophospholipase activity and , isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic , acid constructs, vectors and host cells comprising the nucleic acid sequences as well as methods , for producing and using the polypeptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.